Digital Respiratory Devices Market is expected to expand at a CAGR of 25% to reach US$ 400 Bn from 2023 to 2032

The digital respiratory devices market has witnessed substantial growth and innovation in recent years. These devices are designed to monitor and manage respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea, using advanced digital technologies. In this paragraph, we will delve into the key factors driving the growth of the digital respiratory devices market.

The global digital respiratory devices market was valued at US$ 43 Billion in 2022 and is expected to expand at a CAGR of 25% from 2022 to 2032. The increased frequency of respiratory disorders has pushed for advancements in the production of breathing equipment.

Need More Insights on Competitor Analysis of the Digital Respiratory Devices Market, Request for Sample@ https://www.persistencemarketresearch.com/samples/33183

One of the primary drivers behind the market's growth is the increasing prevalence of respiratory diseases. The global burden of respiratory conditions is on the rise, attributed to factors like air pollution, smoking, and sedentary lifestyles. As a result, there is a growing need for effective respiratory monitoring and management solutions. Digital respiratory devices offer real-time data collection, analysis, and personalized insights, enabling individuals and healthcare providers to monitor and control respiratory conditions more efficiently.

Companies

COHERO Health Inc.
Cognita Labs
Adherium Limited
Amiko Digital Health Limited
Teva Pharmaceuticals Industries Ltd.
Propeller Health
Novartis AG
Pneuma Respiratory Inc.
3M Health Care Limited
AireHealth, Inc.

If You Want To Know The Business Opportunity/Market Value, Purchase The Premium Insight @ https://www.persistencemarketresearch.com/checkout/33183

Another significant factor contributing to the market's expansion is the rapid advancements in digital health technologies. Innovations such as wearable sensors, mobile apps, and cloud computing have paved the way for the development of digital respiratory devices. These devices can track various respiratory parameters, including lung function, oxygen saturation levels, cough frequency, and medication adherence. The integration of wireless connectivity and data analytics capabilities further enhances the usability and effectiveness of these devices.

The increasing adoption of telehealth and remote patient monitoring solutions has also played a vital role in driving the digital respiratory devices market. Telehealth services allow patients to receive virtual consultations, monitor their health remotely, and share real-time data with healthcare professionals. Digital respiratory devices seamlessly integrate with telehealth platforms, enabling remote monitoring of respiratory conditions and facilitating timely interventions. This remote monitoring approach not only improves patient convenience but also reduces the burden on healthcare systems and enhances access to care, particularly in remote areas.

Moreover, the COVID-19 pandemic has accelerated the demand for digital respiratory devices. Respiratory complications are a significant concern in COVID-19 cases, and these devices can assist in early detection and remote monitoring of respiratory symptoms. The pandemic has also highlighted the importance of home-based care and self-management for respiratory patients, further driving the adoption of digital respiratory devices that enable continuous monitoring and self-assessment.

Recent Developments:

In September 2021, Adherium Limited, a market leader in respiratory eHealth, remote monitoring, and data management, announced that the FDA's 510(k) approval has allowed it to begin selling its first, next-generation Hailie Sensor, which includes physiological measures for tracking the use of asthma and COPD medications.

In November 2019, Propeller Health expanded their pharmacy refill app to cover CVS, Rite-Aid, Kroger, and Walmart pharmacies.

In January 2019, Propeller Health also launched My Drugstore, an in-app service in collaboration with Walgreens that allows clients to manage their medication refills for COPD and asthma and locate a nearby pharmacy.

If you want to Purchase Specific Insights by Segment/Region/Competitor, Request For Customization @ https://www.persistencemarketresearch.com/request-customization/33183

Key Segments in Digital Respiratory Devices Industry Research

By Product

Smart Inhalers & Nebulizers
Sensors & Apps

By Indication

Asthma
COPD
Other Diseases

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By End Use

Hospitals
Homecare Settings
Other settings

By Region

North America
Europe
East Asia
South Asia
Oceania
Latin America
Middle East & Africa

Top Market Research Report:

Water Soluble Fertilizers Market: https://www.persistencemarketresearch.com/market-research/water-soluble-fertilizers-market.asp

Polymerase Chain Reaction Market: https://www.persistencemarketresearch.com/market-research/polymerase-chain-reaction-market.asp

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.